Development of composition and evaluation of equivalence of diacerein hard gelatin capsules

Development of composition and evaluation of equivalence of diacerein hard gelatin capsules

Diacerein is a new generation of symptomatic slow-acting agent for the treatment of osteoarthritis, when taken orally, it exhibits moderate anti-inflammatory and analgesic activity, slows down the decay of cartilage tissue and relieves pain and swelling, but its physicochemical properties it is prac...

Full description

Bibliographic Details
Main Authors:	O. O. Saliy, O. V. Los, O. P. Baula, V. U. Turchyna
Format:	Article
Language:	Ukrainian
Published:	The State Expert Center of the Ministry of Health of Ukraine 2021-12-01
Series:	Фармацевтичний журнал
Subjects:	diacerein solubility pharmaco-technological properties dissolution kinetics
Online Access:	https://pharmj.org.ua/index.php/journal/article/view/1261/1184

Similar Items

Differential scanning calorimetry: A screening tool for the development of diacerein eutectics
by: Rajeshri D. Patel, et al.
Published: (2022-01-01)

Diacerein, its beneficial impact on chondrocytes and notable new clinical applications
by: Daljit Kaur, et al.
Published: (2019-04-01)

PREPARATION AND CHARACTERIZATION OF CO-CRYSTALS OF DIACEREIN
by: Raju Rameshrao Thenge, et al.
Published: (2017-01-01)

Diacerein: A potential therapeutic drug for the management of experimental periodontitis in rats
by: Basma Mostafa Zaki, et al.
Published: (2015-09-01)

Diacerein: Advantages and disadvantages
by: Andrei Evgenyevich Karateev
Published: (2014-12-01)

Prediction of diacerein inhibition activity against interleukin-1 receptors through docking method and tracing of pharmacokinetic profiles and their toxicity
by: Frengki Frengki, et al.
Published: (2020-11-01)

DIACEREIN AS THE DRUG OF CHOICE IN THE THERAPY OF KNEE OSTEOARTHRITIS WITH SECONDARY RECURRENT SYNOVITIS
by: M. I. Udovika
Published: (2016-02-01)

Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
by: Miriam Méndez-del Villar, et al.
Published: (2017-02-01)

Topical Diacerein Decreases Skin and Splenic CD11c<sup>+</sup> Dendritic Cells in Psoriasis
by: Susanne M. Brunner, et al.
Published: (2023-02-01)

In vitro antibiofilm and bacteriostatic activity of diacerein against Enterococcus faecalis
by: Chunyan Fu, et al.
Published: (2023-08-01)

EVALUATION OF THE EFFICACY AND SAFETY OF DIACEREIN IN PATIENTS WITH OSTEOARTHRITIS OF THE HIP JOINTS
by: E. P. Sharapova, et al.
Published: (2017-12-01)

Diacerein in the treatment of chronic plaque psoriasis: A case report
by: Kalgi Baxi, et al.
Published: (2022-01-01)

Diacerein the treatment of osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2016-12-01)

Diacerein-Loaded Hyaluosomes as a Dual-Function Platform for Osteoarthritis Management via Intra-Articular Injection: In Vitro Characterization and In Vivo Assessment in a Rat Model
by: Nouran O. Eladawy, et al.
Published: (2021-05-01)

Diacerein versus non-steroidal anti-inflammatory drugs in the treatment of knee osteoarthritis: a meta-analysis
by: Fan Zeng, et al.
Published: (2023-04-01)

Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex
by: Michael Ablinger, et al.
Published: (2018-11-01)

Anti-Contractile and Anti-Inflammatory Effects of Diacerein on Isolated Mouse Airways Smooth Muscle and Mouse Asthma Model
by: Shunbo Shi, et al.
Published: (2020-09-01)

Validated determination of diacerein and its active metabolite, rhein, by stability indicating constant pattern method as a novel manipulation of zero order spectra
by: Aml A. Emam, et al.
Published: (2018-06-01)

Outcomes of the use of the glycosaminoglycan-peptide complex as monotherapy and in combination with diacerein for the treatment of knee osteoarthritis in real-world practice
by: Andrey E. Karateev, et al.
Published: (2023-05-01)

The effect of food intake on the pk of rhein released from diacerein
by: Ming Huang, et al.
Published: (2020-04-01)

ESTIMATION OF DIACEREIN TOLERABILITY IN REAL CLINICAL PRACTICE: RESULTS OF THE RACADA (RETROSPECTIVE ASSESSMENT OF CLINICAL ASPECTS OF USING DIAFLEX IN OSTEOARTHRITIS)
by: A. E. Karateev, et al.
Published: (2015-04-01)

Corneal pharmacokinetics of the 2% diacerein eye drops between multiple administration and single administration
by: Ke Yang, et al.
Published: (2018-04-01)

Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation
by: Allam AN, et al.
Published: (2017-07-01)

Inhibition of inflammation using diacerein markedly improved renal function in endotoxemic acute kidney injured mice
by: Guangzhe Yu, et al.
Published: (2018-08-01)

Betaine- and L-Carnitine-Based Ionic Liquids as Solubilising and Stabilising Agents for the Formulation of Antimicrobial Eye Drops Containing Diacerein
by: Brunella Grassiri, et al.
Published: (2023-02-01)

Interleukin-6 expression and its modulation by diacerein in a rat model of chronic stress induced cardiac dysfunction
by: Vipul Agarwal, et al.
Published: (2021-12-01)

Challenges of Dissolution Methods Development for Soft Gelatin Capsules
by: Festo Damian, et al.
Published: (2021-02-01)

Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation
by: Diana E. Aziz, et al.
Published: (2018-01-01)

NEW OPPORTUNITIES THERAPY IN PATIENTS WITH KNEE JOINT OSTEOARTHRITIS AND METABOLIC SYNDROME
by: L. I. Alexeeva, et al.
Published: (2018-02-01)

Study protocol for a randomised controlled trial of diacerein versus placebo to treat knee osteoarthritis with effusion-synovitis (DICKENS)
by: Guoqi Cai, et al.
Published: (2022-09-01)

Highly Polymorphic Materials and Dissolution Behaviour: The Peculiar Case of Rifaximin
by: Annalisa Bianchera, et al.
Published: (2022-12-01)

Efficacy of combined use of glycosaminoglycan peptide complex for intramuscular administration and oral diacerein in osteoarthritis: evaluation according to an observational multicenter clinical trial
by: Andrei E. Karateev, et al.
Published: (2021-05-01)

Analysis of Dissolution of Salicylamide from Carrageenan Based Hard-Shell Capsules: A Study of the Drug-Matrix Interaction
by: Muhammad Al Rizqi Dharma Fauzi, et al.
Published: (2020-11-01)

A rapid and simple RP-HPLC method for quantification of desipramine in human plasma
by: Önal Armağan, et al.
Published: (2011-11-01)

Semisolid matrix-filled hard gelatin capsules for rapid dissolution of amlodipine besilate: Development and assessment
by: Vijay K Tyagi, et al.
Published: (2013-01-01)

KNEE OSTEOARTHRITIS AND METABOLIC SYNDROME: NEW APPROACHES TO THERAPY
by: L. I. Alekseeva, et al.
Published: (2018-05-01)

Self-nanoemulsifying drug-delivery systems for potentiated anti-inflammatory activity of diacerein
by: Eltobshi AA, et al.
Published: (2018-10-01)

Pain type in osteoarthritis. Approaches to treatment
by: R.M. Balabanova
Published: (2014-05-01)

A comparative study of two separate analytical techniques for the simultaneous determination of diclofenac sodium and diacerein from combined dosage form
by: Sanhita Basu Mallick, et al.
Published: (2017-06-01)

Farmacovigilancia de medicamentos cubanos en revistas médicas nacionales
by: María Aida Cruz Barrios, et al.